检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial

Anders Svenningsson,Thomas Frisell,Joachim Burman,Jonatan Salzer,Katharina Fink, Susanna Hallberg, Joakim Hambraeus,Markus Axelsson,Faiez Al Nimer,Peter Sundström,Martin Gunnarsson,Rune Johansson,Johan Mellergård,Igal Rosenstein,Ahmad Ayad, Irina Sjöblom,Anette Risedal,Pierre de Flon, Eric Gilland, Jonas Lindeberg

The Lancet Neurology（2022）

引用 29|浏览7
暂无评分
摘要
Swedish Research Council.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要